ExploreWatchlistsPricing
  1. JP-listed companies
  2. Japan Tissue Engineering Co., Ltd.
  3. Financials
  4. Total assets

Japan Tissue Engineering Co., Ltd. (7774)

Market cap
¥24.5B
P/E ratio
-45.3x
Develops and manufactures regenerative medicine products that restore tissue function by culturing patients' own cells for transplantation.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndTotal assets (Million JPY)YoY (%)
Mar 31, 20256,513-6.81%
Mar 31, 20246,989+1.53%
Mar 31, 20236,883-9.41%
Mar 31, 20227,598-6.42%
Mar 31, 20218,119-3.93%
Mar 31, 20208,452-3.43%
Mar 31, 20198,752-3.00%
Mar 31, 20189,023+5.58%
Mar 31, 20178,546+3.01%
Mar 31, 20168,297-6.29%
Mar 31, 20158,853

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat